Higher tacrolimus concentrations early after transplant reduce the risk of acute GvHD in reduced-intensity allogeneic stem cell transplantation von Ganetsky, A, Shah, A, Miano, T A, Hwang, W-T, He, J, Loren, A W, Hexner, E O, Frey, N V, Porter, D L, Reshef, R

Volltext

High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCT von Tizon, R, Frey, N, Heitjan, D F, Tan, K S, Goldstein, S C, Hexner, E O, Loren, A, Luger, S M, Reshef, R, Tsai, D, Vogl, D, Davis, J, Vozniak, M, Fuchs, B, Stadtmauer, E A, Porter, D L

Volltext

Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD von Rager, A, Frey, N, Goldstein, S C, Reshef, R, Hexner, E O, Loren, A, Luger, S M, Perl, A, Tsai, D, Davis, J, Vozniak, M, Smith, J, Stadtmauer, E A, Porter, D L

Volltext

S830 AVAPRITINIB, A POTENT AND SELECTIVE INHIBITOR OF KIT D816V, INDUCES COMPLETE AND DURABLE RESPONSES IN PATIENTS (PTS) WITH ADVANCED SYSTEMIC MASTOCYTOSIS (ADVSM) von Radia, D., Deininger, M.W., Gotlib, J., Bose, P., Drummond, M.W., Hexner, E.O., Robinson, W.A., Quiery, A.T., Winton, E., George, T.I., Horny, H.‐P., Oren, R., Shi, H., Schmidt‐Kittler, O., Mar, B., DeAngelo, D.J.

Volltext

Feasibility, Safety and Efficacy of Maraviroc, a CCR5 Antagonist, in Graft-Versus-Host Disease Prevention After Reduced intensity Conditioned (RIC) Allogeneic Stem Cell Transplant... von Reshef, R, Luger, S.M, Loren, A.W, Frey, N.V, Goldstein, S.C, Hexner, E.O, Stadtmauer, E.A, Smith, J, Mick, R, Heitjan, D.F, Hoxie, J.A, Emerson, S.G, Vonderheide, R.H, Porter, D.L

Volltext